CNTO 2476

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CNTO 2476, covering 2014-06-26 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) [Phase 2]

See pricing